Copyright Reports & Markets. All rights reserved.

Global Fermentation-derived Antibiotic APIs Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Fermentation-derived Antibiotic APIs Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 β-lactams
    • 1.3.3 Non-β-lactam
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Fermentation-derived Antibiotic APIs Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospitals
    • 1.4.3 Laboratories
    • 1.4.4 Pharmaceutical Companies
  • 1.5 Global Fermentation-derived Antibiotic APIs Market Size & Forecast
    • 1.5.1 Global Fermentation-derived Antibiotic APIs Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Fermentation-derived Antibiotic APIs Sales Quantity (2020-2031)
    • 1.5.3 Global Fermentation-derived Antibiotic APIs Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Merck
    • 2.1.1 Merck Details
    • 2.1.2 Merck Major Business
    • 2.1.3 Merck Fermentation-derived Antibiotic APIs Product and Services
    • 2.1.4 Merck Fermentation-derived Antibiotic APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Merck Recent Developments/Updates
  • 2.2 Ajinomoto
    • 2.2.1 Ajinomoto Details
    • 2.2.2 Ajinomoto Major Business
    • 2.2.3 Ajinomoto Fermentation-derived Antibiotic APIs Product and Services
    • 2.2.4 Ajinomoto Fermentation-derived Antibiotic APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Ajinomoto Recent Developments/Updates
  • 2.3 Harbin Pharmaceutical Group
    • 2.3.1 Harbin Pharmaceutical Group Details
    • 2.3.2 Harbin Pharmaceutical Group Major Business
    • 2.3.3 Harbin Pharmaceutical Group Fermentation-derived Antibiotic APIs Product and Services
    • 2.3.4 Harbin Pharmaceutical Group Fermentation-derived Antibiotic APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Harbin Pharmaceutical Group Recent Developments/Updates
  • 2.4 Huaxing Pharmaceutical
    • 2.4.1 Huaxing Pharmaceutical Details
    • 2.4.2 Huaxing Pharmaceutical Major Business
    • 2.4.3 Huaxing Pharmaceutical Fermentation-derived Antibiotic APIs Product and Services
    • 2.4.4 Huaxing Pharmaceutical Fermentation-derived Antibiotic APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Huaxing Pharmaceutical Recent Developments/Updates
  • 2.5 North China Pharmaceutical
    • 2.5.1 North China Pharmaceutical Details
    • 2.5.2 North China Pharmaceutical Major Business
    • 2.5.3 North China Pharmaceutical Fermentation-derived Antibiotic APIs Product and Services
    • 2.5.4 North China Pharmaceutical Fermentation-derived Antibiotic APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 North China Pharmaceutical Recent Developments/Updates
  • 2.6 Tianjin Pharmaceutical
    • 2.6.1 Tianjin Pharmaceutical Details
    • 2.6.2 Tianjin Pharmaceutical Major Business
    • 2.6.3 Tianjin Pharmaceutical Fermentation-derived Antibiotic APIs Product and Services
    • 2.6.4 Tianjin Pharmaceutical Fermentation-derived Antibiotic APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Tianjin Pharmaceutical Recent Developments/Updates
  • 2.7 DSM
    • 2.7.1 DSM Details
    • 2.7.2 DSM Major Business
    • 2.7.3 DSM Fermentation-derived Antibiotic APIs Product and Services
    • 2.7.4 DSM Fermentation-derived Antibiotic APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 DSM Recent Developments/Updates
  • 2.8 Tianjin Pharmaceutical Group
    • 2.8.1 Tianjin Pharmaceutical Group Details
    • 2.8.2 Tianjin Pharmaceutical Group Major Business
    • 2.8.3 Tianjin Pharmaceutical Group Fermentation-derived Antibiotic APIs Product and Services
    • 2.8.4 Tianjin Pharmaceutical Group Fermentation-derived Antibiotic APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Tianjin Pharmaceutical Group Recent Developments/Updates
  • 2.9 CSPC
    • 2.9.1 CSPC Details
    • 2.9.2 CSPC Major Business
    • 2.9.3 CSPC Fermentation-derived Antibiotic APIs Product and Services
    • 2.9.4 CSPC Fermentation-derived Antibiotic APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 CSPC Recent Developments/Updates
  • 2.10 Northeast Pharmaceutical
    • 2.10.1 Northeast Pharmaceutical Details
    • 2.10.2 Northeast Pharmaceutical Major Business
    • 2.10.3 Northeast Pharmaceutical Fermentation-derived Antibiotic APIs Product and Services
    • 2.10.4 Northeast Pharmaceutical Fermentation-derived Antibiotic APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Northeast Pharmaceutical Recent Developments/Updates
  • 2.11 Lukang
    • 2.11.1 Lukang Details
    • 2.11.2 Lukang Major Business
    • 2.11.3 Lukang Fermentation-derived Antibiotic APIs Product and Services
    • 2.11.4 Lukang Fermentation-derived Antibiotic APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Lukang Recent Developments/Updates
  • 2.12 Luwei Pharmaceutical
    • 2.12.1 Luwei Pharmaceutical Details
    • 2.12.2 Luwei Pharmaceutical Major Business
    • 2.12.3 Luwei Pharmaceutical Fermentation-derived Antibiotic APIs Product and Services
    • 2.12.4 Luwei Pharmaceutical Fermentation-derived Antibiotic APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Luwei Pharmaceutical Recent Developments/Updates
  • 2.13 Sinopharm Group
    • 2.13.1 Sinopharm Group Details
    • 2.13.2 Sinopharm Group Major Business
    • 2.13.3 Sinopharm Group Fermentation-derived Antibiotic APIs Product and Services
    • 2.13.4 Sinopharm Group Fermentation-derived Antibiotic APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Sinopharm Group Recent Developments/Updates
  • 2.14 Chuanning Biopharm
    • 2.14.1 Chuanning Biopharm Details
    • 2.14.2 Chuanning Biopharm Major Business
    • 2.14.3 Chuanning Biopharm Fermentation-derived Antibiotic APIs Product and Services
    • 2.14.4 Chuanning Biopharm Fermentation-derived Antibiotic APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Chuanning Biopharm Recent Developments/Updates
  • 2.15 United Pharmaceutical
    • 2.15.1 United Pharmaceutical Details
    • 2.15.2 United Pharmaceutical Major Business
    • 2.15.3 United Pharmaceutical Fermentation-derived Antibiotic APIs Product and Services
    • 2.15.4 United Pharmaceutical Fermentation-derived Antibiotic APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 United Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Fermentation-derived Antibiotic APIs by Manufacturer

  • 3.1 Global Fermentation-derived Antibiotic APIs Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Fermentation-derived Antibiotic APIs Revenue by Manufacturer (2020-2025)
  • 3.3 Global Fermentation-derived Antibiotic APIs Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Fermentation-derived Antibiotic APIs by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Fermentation-derived Antibiotic APIs Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Fermentation-derived Antibiotic APIs Manufacturer Market Share in 2024
  • 3.5 Fermentation-derived Antibiotic APIs Market: Overall Company Footprint Analysis
    • 3.5.1 Fermentation-derived Antibiotic APIs Market: Region Footprint
    • 3.5.2 Fermentation-derived Antibiotic APIs Market: Company Product Type Footprint
    • 3.5.3 Fermentation-derived Antibiotic APIs Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Fermentation-derived Antibiotic APIs Market Size by Region
    • 4.1.1 Global Fermentation-derived Antibiotic APIs Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Fermentation-derived Antibiotic APIs Consumption Value by Region (2020-2031)
    • 4.1.3 Global Fermentation-derived Antibiotic APIs Average Price by Region (2020-2031)
  • 4.2 North America Fermentation-derived Antibiotic APIs Consumption Value (2020-2031)
  • 4.3 Europe Fermentation-derived Antibiotic APIs Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Fermentation-derived Antibiotic APIs Consumption Value (2020-2031)
  • 4.5 South America Fermentation-derived Antibiotic APIs Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Fermentation-derived Antibiotic APIs Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Fermentation-derived Antibiotic APIs Sales Quantity by Type (2020-2031)
  • 5.2 Global Fermentation-derived Antibiotic APIs Consumption Value by Type (2020-2031)
  • 5.3 Global Fermentation-derived Antibiotic APIs Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Fermentation-derived Antibiotic APIs Sales Quantity by Application (2020-2031)
  • 6.2 Global Fermentation-derived Antibiotic APIs Consumption Value by Application (2020-2031)
  • 6.3 Global Fermentation-derived Antibiotic APIs Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Fermentation-derived Antibiotic APIs Sales Quantity by Type (2020-2031)
  • 7.2 North America Fermentation-derived Antibiotic APIs Sales Quantity by Application (2020-2031)
  • 7.3 North America Fermentation-derived Antibiotic APIs Market Size by Country
    • 7.3.1 North America Fermentation-derived Antibiotic APIs Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Fermentation-derived Antibiotic APIs Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Fermentation-derived Antibiotic APIs Sales Quantity by Type (2020-2031)
  • 8.2 Europe Fermentation-derived Antibiotic APIs Sales Quantity by Application (2020-2031)
  • 8.3 Europe Fermentation-derived Antibiotic APIs Market Size by Country
    • 8.3.1 Europe Fermentation-derived Antibiotic APIs Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Fermentation-derived Antibiotic APIs Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Fermentation-derived Antibiotic APIs Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Fermentation-derived Antibiotic APIs Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Fermentation-derived Antibiotic APIs Market Size by Region
    • 9.3.1 Asia-Pacific Fermentation-derived Antibiotic APIs Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Fermentation-derived Antibiotic APIs Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Fermentation-derived Antibiotic APIs Sales Quantity by Type (2020-2031)
  • 10.2 South America Fermentation-derived Antibiotic APIs Sales Quantity by Application (2020-2031)
  • 10.3 South America Fermentation-derived Antibiotic APIs Market Size by Country
    • 10.3.1 South America Fermentation-derived Antibiotic APIs Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Fermentation-derived Antibiotic APIs Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Fermentation-derived Antibiotic APIs Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Fermentation-derived Antibiotic APIs Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Fermentation-derived Antibiotic APIs Market Size by Country
    • 11.3.1 Middle East & Africa Fermentation-derived Antibiotic APIs Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Fermentation-derived Antibiotic APIs Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Fermentation-derived Antibiotic APIs Market Drivers
  • 12.2 Fermentation-derived Antibiotic APIs Market Restraints
  • 12.3 Fermentation-derived Antibiotic APIs Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Fermentation-derived Antibiotic APIs and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Fermentation-derived Antibiotic APIs
  • 13.3 Fermentation-derived Antibiotic APIs Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Fermentation-derived Antibiotic APIs Typical Distributors
  • 14.3 Fermentation-derived Antibiotic APIs Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Fermentation-derived Antibiotic APIs market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    Fermentation-derived antibiotic APIs are active pharmaceutical ingredients produced via microbial fermentation. These antibiotics are secondary metabolites generated by specific microorganisms (e.g., bacteria, actinomycetes, or fungi) during the fermentation process and exhibit antibacterial properties, commonly used in anti-infective drugs.
    This report is a detailed and comprehensive analysis for global Fermentation-derived Antibiotic APIs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Fermentation-derived Antibiotic APIs market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
    Global Fermentation-derived Antibiotic APIs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
    Global Fermentation-derived Antibiotic APIs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
    Global Fermentation-derived Antibiotic APIs market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Fermentation-derived Antibiotic APIs
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Fermentation-derived Antibiotic APIs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Ajinomoto, Harbin Pharmaceutical Group, Huaxing Pharmaceutical, North China Pharmaceutical, Tianjin Pharmaceutical, DSM, Tianjin Pharmaceutical Group, CSPC, Northeast Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Fermentation-derived Antibiotic APIs market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    β-lactams
    Non-β-lactam
    Market segment by Application
    Hospitals
    Laboratories
    Pharmaceutical Companies
    Major players covered
    Merck
    Ajinomoto
    Harbin Pharmaceutical Group
    Huaxing Pharmaceutical
    North China Pharmaceutical
    Tianjin Pharmaceutical
    DSM
    Tianjin Pharmaceutical Group
    CSPC
    Northeast Pharmaceutical
    Lukang
    Luwei Pharmaceutical
    Sinopharm Group
    Chuanning Biopharm
    United Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Fermentation-derived Antibiotic APIs product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Fermentation-derived Antibiotic APIs, with price, sales quantity, revenue, and global market share of Fermentation-derived Antibiotic APIs from 2020 to 2025.
    Chapter 3, the Fermentation-derived Antibiotic APIs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Fermentation-derived Antibiotic APIs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Fermentation-derived Antibiotic APIs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Fermentation-derived Antibiotic APIs.
    Chapter 14 and 15, to describe Fermentation-derived Antibiotic APIs sales channel, distributors, customers, research findings and conclusion.

    Buy now